Capobianco M - Search Results

1

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations.

Bertolotto A, Malucchi S, Milano E, Castello A, Capobianco M, Mutani R. Bertolotto A, et al. Among authors: capobianco m. Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x. Immunopharmacology. 2000. PMID: 10936507

2

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.

Bertolotto A, Capobianco M, Malucchi S, Manzardo E, Audano L, Bergui M, Bradac GB, Mutani R. Bertolotto A, et al. Among authors: capobianco m. Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0. Neurosci Lett. 1999. PMID: 10218901

3

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses.

Bertolotto A, Malucchi S, Capobianco M, Manzardo E, Guastamacchia G, Milano E, Audano L, Mutani R. Bertolotto A, et al. Among authors: capobianco m. J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703. J Interferon Cytokine Res. 1999. PMID: 10433357

4

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

Bertolotto A, Malucchi S, Sala A, Orefice G, Carrieri PB, Capobianco M, Milano E, Melis F, Giordana MT. Bertolotto A, et al. Among authors: capobianco m. J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148. J Neurol Neurosurg Psychiatry. 2002. PMID: 12122172 Free PMC article.

5

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

Bertolotto A, Gilli F, Sala A, Capobianco M, Malucchi S, Milano E, Melis F, Marnetto F, Lindberg RL, Bottero R, Di Sapio A, Giordana MT. Bertolotto A, et al. Among authors: capobianco m. Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5. Neurology. 2003. PMID: 12601105 Clinical Trial.

6

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.

Milano E, Di Sapio A, Malucchi S, Capobianco M, Bottero R, Sala A, Gilli F, Bertolotto A. Milano E, et al. Among authors: capobianco m. Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y. Neurol Sci. 2003. PMID: 14600824

7

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis.

Malucchi S, Sala A, Gilli F, Bottero R, Di Sapio A, Capobianco M, Bertolotto A. Malucchi S, et al. Among authors: capobianco m. Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e. Neurology. 2004. PMID: 15184610

8

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

Bertolotto A, Sala A, Malucchi S, Marnetto F, Caldano M, Di Sapio A, Capobianco M, Gilli F. Bertolotto A, et al. Among authors: capobianco m. J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259. J Neurol Neurosurg Psychiatry. 2004. PMID: 15314118 Free PMC article. Clinical Trial.

9

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

Gilli F, Marnetto F, Caldano M, Sala A, Malucchi S, Di Sapio A, Capobianco M, Bertolotto A. Gilli F, et al. Among authors: capobianco m. J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006. J Neuroimmunol. 2005. PMID: 15589054 Clinical Trial.

10

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study.

Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani N, Milanese C, Moiola L, Patti F, Pilato V, Pozzilli C, Trojano M, Zaffaroni M, Comi G; Immunomodulatory Treatment of Early onset MS Group. Ghezzi A, et al. Among authors: capobianco m. Mult Scler. 2005 Aug;11(4):420-4. doi: 10.1191/1352458505ms1206oa. Mult Scler. 2005. PMID: 16042224 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters